Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iLux Treatment for Meibomian Gland Dysfunction (MGD)

NCT03055650 is registered in ClinicalTrials.gov with Tear Film Innovations, Inc. as lead sponsor.

NCT NCT03055650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03055650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iLux Treatment for Meibomian Gland Dysfunction (MGD)
Lead sponsor
Tear Film Innovations, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 7, 2015
Completion date
February 18, 2016
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

evaporative dry eye